Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography  Young–Joo Jin, So–Yun Nah, Jin–Woo Lee, Jung–Il Lee, Seok Jeong, Don Haeng Lee, Young Soo Kim, Soon Gu Cho, Yong Sun Jeon  Clinical Gastroenterology and Hepatology  Volume 11, Issue 2, Pages 187-192 (February 2013) DOI: 10.1016/j.cgh.2012.11.002 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Atypical nodule on Primovist-enhanced MR image. Primovist-enhanced MRI depicted an atypical nodule with subtle arterial enhancement (A, long arrow) and delayed washout (B, long arrow) on dynamic phase with slight hypointensity on hepatobiliary phase (C, long arrow). CTHA and CTAP showed arterial enhancement (D, long arrow) and perfusion defect (E, long arrow), respectively. Angiography showed hypervascular tumor staining on atypical nodule (long arrow, F) and on the primary definite HCC (short arrow, F). Clinical Gastroenterology and Hepatology 2013 11, 187-192DOI: (10.1016/j.cgh.2012.11.002) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Clinical impact of Primovist-enhanced MRI on BCLC stage. Twelve patients (11.5%) showed a change in BCLC stage, from 0 to A (5/31, 16.1%) and from A to B (7/73, 9.6%), after Primovist-enhanced MRI. Clinical Gastroenterology and Hepatology 2013 11, 187-192DOI: (10.1016/j.cgh.2012.11.002) Copyright © 2013 AGA Institute Terms and Conditions